There are 859 resources available
360MO - Pembrolizumab plus nab-paclitaxel and platinum as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (R/M HNSCC): A prospective phase II study
Presenter: Xinrui Chen
Session: Mini oral session: Head and neck cancer
Resources:
Abstract
Slides
Webcast
433MO - Tofacitinib for the treatment of immune-related adverse events in cancer immunotherapy: A multi-center study
Presenter: Qing Liu
Session: Mini oral session: Supportive and palliative care
Resources:
Abstract
Slides
Webcast
Q&A and discussion
Presenter: All Speakers
Session: Epidermal growth factor receptor (EGFR) mutations in early stage non-small cell lung cancer: Do we know it all?
Resources:
Webcast
Q&A and discussion
Presenter: All Speakers
Session: Demystifying the treatment of uterine leiomyosarcoma (uLMS)
Resources:
Webcast
361MO - Characterizing the role of NSD family of histone methyltransferases in the head and neck squamous cell carcinoma tumor immune microenvironment
Presenter: Yanis Boumber
Session: Mini oral session: Head and neck cancer
Resources:
Abstract
Slides
Webcast
434MO - Increased eosinophil is a universal biomarker for immune-related adverse events induced by immune checkpoint inhibitors in various cancer patients: A retrospective multidisciplinary study
Presenter: yoshihiko tasaki
Session: Mini oral session: Supportive and palliative care
Resources:
Abstract
Slides
Webcast
Invited Discussant 91MO and 92MO
Presenter: Iain Tan
Session: Mini oral session 1: Gastrointestinal tumours
Resources:
Slides
Webcast
Invited Discussant 359MO, 360MO and 361MO
Presenter: Bhumsuk Keam
Session: Mini oral session: Head and neck cancer
Resources:
Slides
Webcast
Invited Discussant 433MO and 434MO
Presenter: Jayne Wood
Session: Mini oral session: Supportive and palliative care
Resources:
Slides
Webcast
Q&A and discussion
Presenter: All Speakers
Session: Mini oral session 1: Gastrointestinal tumours
Resources:
Webcast